Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous CIK Cells for CML
NCT00815321Phase 2Completed
- Sponsor
- Singapore General Hospital
- Start
- Dec 2008
- Primary completion
- Nov 2011
- Modality
- Prophylactic Vaccines, Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs)
- Countries
- 1
01
Overview
A Phase 2 trial of autologous cytokine-induced killer cells in chronic myeloid leukemia (CML), sponsored by Singapore General Hospital. Started Dec 2008; status: completed.
02
Drugs
autologous cytokine-induced killer cells
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT00815321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00815321.